The Company

Bn’ML – Behavioral & Molecular Lab appears in 2012 as a Start-up of the Portuguese University of Minho, in close association with the Life and Health Sciences Research Institute (ICVS), which integrates the ICVS/3B´s – a Portuguese Government Associate Laboratory.

Bn´ML mission is to optimize the sorting process of therapeutic compounds, in a preclinical phase, sustaining the investment associated with the transition to a later clinical-trials phase. The company delivers customized behavioral and molecular analysis services for testing the potential of new therapeutic compounds.

Bn’ML provides on-time and cost-effective services using pre-validated and reliable animal models of disease.


Where do we stand?

Bn’ML tests the potential of therapeutic compounds, both at the behavioral and molecular levels, in animal models of disease, thus adding an extra dimension to the preclinical tests phase. In this way, the company allows a comprehensive evaluation of the therapeutic compounds effects, sustaining the investment associated to the transition to a clinical trials phase.


Prizes and Distinctions

1st Award - SpinUM Business Ideas Contest 2011, TecMinho

SpinUM Young Entrepreneurs Prize 2011, TecMinho



Bn’ML intends to be an essential partner of the international pharmaceutical industry, in the preclinical phase of development and validation of new therapeutic compounds. For that, the company is building up its strategy in the expertise of a multidisciplinary team specialized in cutting-edge technology and in the development of new testing solutions to meet our customers’ requests.